SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-08-000215
Filing Date
2008-03-17
Accepted
2008-03-17 17:28:07
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a39051e10vk.htm 10-K 606830
2 EXHIBIT 10.71 a39051exv10w71.htm EX-10.71 21398
3 EXHIBIT 23.1 a39051exv23w1.htm EX-23.1 1610
4 EXHIBIT 31.1 a39051exv31w1.htm EX-31.1 8142
5 EXHIBIT 31.2 a39051exv31w2.htm EX-31.2 8141
6 EXHIBIT 32.1 a39051exv32w1.htm EX-32.1 4913
7 GRAPHIC a39051a3905101.gif GRAPHIC 9418
  Complete submission text file 0000936392-08-000215.txt   665571
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24274 | Film No.: 08694171
SIC: 2836 Biological Products, (No Diagnostic Substances)